Document Detail


Effect of exercise on postmenopausal sex hormone levels and role of body fat: a randomized controlled trial.
MedLine Citation:
PMID:  19687339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To examine the effects of a 1-year exercise intervention on sex hormone levels in postmenopausal women and whether any effects are mediated by changes in body fat composition. METHODS: We randomly assigned 189 sedentary postmenopausal women (age 50 to 69 years, body mass index of 22 to 40 kg/m(2)) to an exercise intervention (n = 96) or a control group (n = 93). The intervention combined aerobic and strength training and comprised supervised group sessions and home-based exercises (a total of 2.5 h/wk). Between-group differences in sex hormone levels (at baseline and 4 and 12 months) were examined with generalized estimating equations. RESULTS: In total, 183 women (97%) completed the study. Overall, the exercise intervention did not result in favorable effects on sex hormone levels. Among women who lost more than 2% body fat, declines in all estrogens were not significantly different between exercisers and controls. Androgen levels decreased significantly in the exercise group who lost body fat compared with their peers in the control group. Furthermore, this study confirmed that fat loss was significantly associated with declines in postmenopausal estrogen levels. Although not significant, a similar trend was observed for the androgens. CONCLUSION: This study confirms that fat loss is associated with changes in postmenopausal sex hormone levels and suggests that exercise may be effective in inducing favorable changes in these hormones.
Authors:
Evelyn M Monninkhof; Miranda J Velthuis; Petra H M Peeters; Jos W R Twisk; Albertine J Schuit
Related Documents :
22100539 - Dynamic hyperinflation during exercise in patients with precapillary pulmonary hyperten...
21487499 - Assessments of nutrient intake and metabolic profiles in korean adolescents according t...
22234669 - Effect of home-based exercise program on lymphedema and quality of life in female postm...
22005099 - Ventilatory inefficiency as a limiting factor for exercise in patients with copd.
20153709 - The effects of exercise on body satisfaction and affect.
21396499 - Resistance exercise for the aging adult: clinical implications and prescription guideli...
10149589 - The diagnostic and prognostic value of exercise electrocardiography in asymptomatic sub...
6748919 - Temporomandibular joint repositioning and exercise performance: a double-blind study.
20410469 - Heart rate variability and muscle sympathetic nerve activity response to acute stress: ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-08-17
Journal Detail:
Title:  Journal of clinical oncology : official journal of the American Society of Clinical Oncology     Volume:  27     ISSN:  1527-7755     ISO Abbreviation:  J. Clin. Oncol.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-10-02     Completed Date:  2009-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309333     Medline TA:  J Clin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4492-9     Citation Subset:  IM    
Affiliation:
University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, STR 6.131, PO Box 85500, 3508 GA Utrecht, the Netherlands. e.monninkhof@umcutrecht.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / physiology*
Androgens / blood*
Biological Markers / blood
Body Composition
Estrogens / blood*
Exercise / physiology*
Female
Humans
Postmenopause
Chemical
Reg. No./Substance:
0/Androgens; 0/Biological Markers; 0/Estrogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a sec...
Next Document:  Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with...